Kewaunee Scientific Corporation has announced a major acquisition, entering into a Securities Purchase Agreement to acquire NYCOM, Inc. for an aggregate purchase price of $55 million. This strategic move is expected to bolster Kewaunee's position in the laboratory apparatus and furniture market.

The acquisition, which was disclosed in a recent SEC filing, is part of Kewaunee's ongoing efforts to expand its product offerings and enhance its competitive edge in the industry. The deal includes customary representations and warranties, as well as indemnification provisions and post-closing covenants.

Background

Kewaunee Scientific Corp, incorporated in Delaware, operates under the SIC code 3821, which pertains to Laboratory Apparatus & Furniture. The company trades on the Nasdaq under the ticker symbol KEQU. In its most recent filings, Kewaunee has been actively engaged in various financial activities, including quarterly reports and other disclosures.

What the Filing Says

According to the SEC filing (accession number 0001193125-26-442777), Kewaunee has agreed to purchase all outstanding equity interests of NYCOM, which will convert to Nycom, LLC, prior to the closing of the transaction. The purchase price is subject to adjustments based on NYCOM's adjusted EBITDA and other customary factors.

The agreement specifies that $30 million of the purchase price will be paid in cash at closing, with part of the funding expected to come from debt financing through PNC Bank. Additionally, $20 million will be financed through a subordinated seller note, and $5 million will be paid in Kewaunee's common stock, subject to a lock-up agreement.

Impact

This acquisition may significantly impact Kewaunee's operations and market presence. By acquiring NYCOM, Kewaunee aims to enhance its product portfolio and potentially increase its market share in the laboratory apparatus and furniture sector. Stakeholders, including employees and shareholders, may experience changes in company dynamics and strategy as a result of this transaction.

What's Next

The filing does not specify what happens next, but the transaction is expected to close by March 31, 2027, unless terminated earlier due to certain conditions outlined in the agreement.